首页> 外文期刊>Evidence-based complementary and alternative medicine: eCAM >The Chinese Herbal Formula Shenzhu Tiaopi Granule Results in Metabolic Improvement in Type 2 Diabetic Rats by Modulating the Gut Microbiota
【24h】

The Chinese Herbal Formula Shenzhu Tiaopi Granule Results in Metabolic Improvement in Type 2 Diabetic Rats by Modulating the Gut Microbiota

机译:中草原公式Shenzhu Tiaopi颗粒导致2型糖尿病大鼠的代谢改善通过调节肠道微生物

获取原文
           

摘要

Objective. The aim of this study is to investigate the implication of the Chinese herbal formula (CHF) Shenzhu tiaopi Granule (STG) in type 2 diabetes mellitus (T2DM) and discuss the mechanisms by which STG regulates the gut microbiota. Method. Goto-Kakizaki (GK) rats and age-matched Wistar (W) rats were acclimatized for 1 week. The GK rats were randomly divided into 3 groups and orally gavaged with saline (model group, M), acarbose (acarbose group, A), and STG (granule of CHF group, G; the component of this formula includes Codonopsis pilosula, Rhizoma Atractylodis, Pinellia, Poria cocos, Pericarpium Citri Reticulatae, Coptis chinensis Franch, and Pueraria). The W rats were orally gavaged with saline (control group, C). The observation time was 8 weeks. The weight, fasting blood glucose (FBG) level, and blood lipid levels were tested. The 16S rRNA genes in the V3-V4 region were sequenced, and the structure of the gut microbiota was analysed. Results. Compared to C, M displayed significant differences in blood glucose, gut microbiota, etc. (P0.05; P0.01). Compared to M, A and G showed a similar reduction in the FBG gain and a shift in the structure of the gut microbiota (P0.05; P0.01). Compared with A, G exhibited a significant decrease in weight, FBG level, and total cholesterol (P0.05). The gut microbiota, Bacteroidetes, the Firmicutes/Bacteroidetes ratio, Allobaculum, and Desulfovibrionaceae were significantly decreased in response to the STG treatment, while Lactobacillus was significantly enriched (P0.05; P0.01). The community composition also differed at the phylum and genus levels based on the linear discriminant analysis effect size and heat map. Conclusion. Our findings suggest that the composition of the gut microbiota was significantly changed in the diabetic GK rats compared with that in the normal W rats. STG treatment can improve glucose and lipid levels and modulate the gut microbiota in T2DM rats.
机译:客观的。本研究的目的是探讨中草原(CHF)氏氏症型糖尿病(T2DM)2型糖尿病(T2DM)的含义,并讨论STG调节肠道微生物的机制。方法。 Goto-Kakizaki(GK)大鼠和年龄匹配的Wistar(W)大鼠适应1周。将GK大鼠随机分为3组,用盐水(模型组,M),氨基糖(Acarbose组,A)和STG(CHF组颗粒,G;该配方的组分包括Codonopsis pilosula,Rhizoma Aractylodis ,Pinellia,poria cocos,pericarpium citri reticilatae,coptis chinensis franch和pueraria)。用盐水(对照组,C)口服瓦尔胃部。观察时间为8周。测试重量,空腹血糖(FBG)水平和血脂水平。测序V3-V4区域中的16S rRNA基因,分析了肠道微生物菌的结构。结果。与C相比,M显示出血糖,肠道微生物瘤等的显着差异(P <0.05; P <0.01)。与M,A和G相比表现出类似的FBG增益和肠道微生物结构的偏移的变化(P <0.05; P <0.01)。与A相比,G表现出重量,FBG水平和总胆固醇的显着降低(P <0.05)。肠道微生物肿块,细菌素,甲状腺菌,Allobaculum和脱硫率响应于STG处理显着降低,而乳​​酸杆菌显着富集(P <0.05; P <0.01)。基于线性判别分析效果和热图,社区组成在门和属级别不同。结论。我们的研究结果表明,与正常的W大鼠相比,糖尿病GK大鼠肠道微生物肿瘤的组成显着变化。 STG治疗可以改善葡萄糖和脂质水平,并在T2DM大鼠中调节肠道微生物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号